Kindly MD | 8-K: FY2025 Q3 Revenue: USD 388.21 K

Revenue: As of FY2025 Q3, the actual value is USD 388.21 K.

EPS: As of FY2025 Q3, the actual value is USD -0.42.

Segment Revenue

• Total Revenue for Q3 2025 was $0.4 million, compared to $0.6 million in Q3 2024, reflecting the results of the Company’s healthcare business.

Operational Metrics

• Total operating expenses in Q3 2025 were $10.8 million, up from $1.7 million in Q3 2024, primarily due to increased SG&A costs related to the Company’s Bitcoin strategy.
• Net Loss for Q3 2025 was $86.0 million or - $0.42 per diluted share, compared to $1.0 million or - $0.17 per diluted share in Q3 2024. The net loss was mainly driven by a $59.8 million non-cash charge related to the loss on acquisition of Nakamoto and a $22.1 million non-cash charge related to an unrealized loss on digital assets.

Cash Flow

• The report does not provide specific figures for operating cash flow or free cash flow for Q3 2025.

Unique Metrics

• As of September 30, 2025, the Company had purchased a cumulative amount of 5,765 Bitcoin at a weighted average price of $118,204.88 per Bitcoin, totaling approximately $681 million. KindlyMD held 5,398 Bitcoin as of November 12, 2025.

Outlook / Guidance

• The Company plans to continue its strategy of disciplined Bitcoin accumulation and strategic investments in Bitcoin-focused companies to compound long-term shareholder value. It aims to integrate high-quality, cash-generating businesses into a unified Bitcoin operating platform to expand its business scope and resilience.